These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10764414)

  • 1. Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase.
    Lipskaia L; Defer N; Esposito G; Hajar I; Garel MC; Rockman HA; Hanoune J
    Circ Res; 2000 Apr; 86(7):795-801. PubMed ID: 10764414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling.
    Tepe NM; Lorenz JN; Yatani A; Dash R; Kranias EG; Dorn GW; Liggett SB
    Biochemistry; 1999 Dec; 38(50):16706-13. PubMed ID: 10600134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction.
    Mougenot N; Mika D; Czibik G; Marcos E; Abid S; Houssaini A; Vallin B; Guellich A; Mehel H; Sawaki D; Vandecasteele G; Fischmeister R; Hajjar RJ; Dubois-Randé JL; Limon I; Adnot S; Derumeaux G; Lipskaia L
    Cardiovasc Res; 2019 Oct; 115(12):1778-1790. PubMed ID: 30605506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor.
    Koch WJ; Rockman HA; Samama P; Hamilton RA; Bond RA; Milano CA; Lefkowitz RJ
    Science; 1995 Jun; 268(5215):1350-3. PubMed ID: 7761854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice.
    Kohout TA; Takaoka H; McDonald PH; Perry SJ; Mao L; Lefkowitz RJ; Rockman HA
    Circulation; 2001 Nov; 104(20):2485-91. PubMed ID: 11705829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs.
    Iaccarino G; Rockman HA; Shotwell KF; Tomhave ED; Koch WJ
    Am J Physiol; 1998 Oct; 275(4):H1298-306. PubMed ID: 9746479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase.
    Vatner DE; Asai K; Iwase M; Ishikawa Y; Wagner TE; Shannon RP; Homcy CJ; Vatner SF
    J Clin Invest; 1998 May; 101(9):1916-22. PubMed ID: 9576756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor.
    Milano CA; Allen LF; Rockman HA; Dolber PC; McMinn TR; Chien KR; Johnson TD; Bond RA; Lefkowitz RJ
    Science; 1994 Apr; 264(5158):582-6. PubMed ID: 8160017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse.
    Tepe NM; Liggett SB
    FEBS Lett; 1999 Sep; 458(2):236-40. PubMed ID: 10481072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved cardiac function despite marked impairment of cAMP generation.
    Gao MH; Lai NC; Tang T; Guo T; Tang R; Chun BJ; Wang H; Dalton NN; Suarez J; Dillmann WH; Hammond HK
    PLoS One; 2013; 8(9):e72151. PubMed ID: 24147149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
    Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
    Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy.
    Roth DM; Gao MH; Lai NC; Drumm J; Dalton N; Zhou JY; Zhu J; Entrikin D; Hammond HK
    Circulation; 1999 Jun; 99(24):3099-102. PubMed ID: 10377071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IP
    Capel RA; Bose SJ; Collins TP; Rajasundaram S; Ayagama T; Zaccolo M; Burton RB; Terrar DA
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H95-H107. PubMed ID: 33064562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice.
    Turki J; Lorenz JN; Green SA; Donnelly ET; Jacinto M; Liggett SB
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10483-8. PubMed ID: 8816827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling beta-adrenergic control of cardiac myocyte contractility in silico.
    Saucerman JJ; Brunton LL; Michailova AP; McCulloch AD
    J Biol Chem; 2003 Nov; 278(48):47997-8003. PubMed ID: 12972422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac G-protein receptor kinase activity: effect of a beta-adrenergic receptor antagonist.
    Hammond HK; Ping P; Insel PA
    Adv Pharmacol; 1998; 42():507-10. PubMed ID: 9327951
    [No Abstract]   [Full Text] [Related]  

  • 17. Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level.
    Liggett SB; Tepe NM; Lorenz JN; Canning AM; Jantz TD; Mitarai S; Yatani A; Dorn GW
    Circulation; 2000 Apr; 101(14):1707-14. PubMed ID: 10758054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality.
    Dash R; Kadambi V; Schmidt AG; Tepe NM; Biniakiewicz D; Gerst MJ; Canning AM; Abraham WT; Hoit BD; Liggett SB; Lorenz JN; Dorn GW; Kranias EG
    Circulation; 2001 Feb; 103(6):889-96. PubMed ID: 11171800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-specific overexpression of the alpha(1) subunit of the L-type voltage-dependent Ca(2+) channel in transgenic mice. Loss of isoproterenol-induced contraction.
    Muth JN; Yamaguchi H; Mikala G; Grupp IL; Lewis W; Cheng H; Song LS; Lakatta EG; Varadi G; Schwartz A
    J Biol Chem; 1999 Jul; 274(31):21503-6. PubMed ID: 10419451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice.
    Rockman HA; Koch WJ; Milano CA; Lefkowitz RJ
    J Mol Med (Berl); 1996 Sep; 74(9):489-95. PubMed ID: 8892053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.